期刊文献+

Simultaneous quantitation of folic acid and 5-methyltetrahydrofolic acid in human plasma by HPLC–MS/MS and its application to a pharmacokinetic study 被引量:2

Simultaneous quantitation of folic acid and 5-methyltetrahydrofolic acid in human plasma by HPLC–MS/MS and its application to a pharmacokinetic study
下载PDF
导出
摘要 A sensitive method based on high-performance liquid chromatography-tandem mass spectrometry (LC- MS/MS) has been developed for the simultaneous determination of folic acid (FA) and its active meta- bolite, 5-methyltetrahydrofolic acid (5-M-THF), in human plasma. The analytes were extracted from plasma with methanol solution containing 10 mg/mL of 2-mercaptoethanol and 0.025% (v/v) ammonium hydroxide. FA and 5-M-THF were more stable after the addition of 2-mercaptoethanol and ammonium hydroxide in the sample preparation procedures of this study than they were in the previously published methods. Chromatographic separation was performed on a Hedera ODS-2 column using a gradient elution system of acetonitrile and 1 mM ammonium acetate buffer solution containing 0.6% formic acid as mobile phase. LC-MS/MS was carried out with an ESI ion-source and operated in the multiple reaction monitoring (MRM) mode. The assay was linear over the concentration ranges of 0.249-19.9 ng/mL for FA, and 5.05-50.5 ng/mL for 5-M-THF. The developed LC-MS/MS method offers increased sensitivity for quantification of FA and 5-M-THF in human plasma and was applicable to a pharmacokinetic study of FA and 5-M-THF. A sensitive method based on high-performance liquid chromatography-tandem mass spectrometry (LC- MS/MS) has been developed for the simultaneous determination of folic acid (FA) and its active meta- bolite, 5-methyltetrahydrofolic acid (5-M-THF), in human plasma. The analytes were extracted from plasma with methanol solution containing 10 mg/mL of 2-mercaptoethanol and 0.025% (v/v) ammonium hydroxide. FA and 5-M-THF were more stable after the addition of 2-mercaptoethanol and ammonium hydroxide in the sample preparation procedures of this study than they were in the previously published methods. Chromatographic separation was performed on a Hedera ODS-2 column using a gradient elution system of acetonitrile and 1 mM ammonium acetate buffer solution containing 0.6% formic acid as mobile phase. LC-MS/MS was carried out with an ESI ion-source and operated in the multiple reaction monitoring (MRM) mode. The assay was linear over the concentration ranges of 0.249-19.9 ng/mL for FA, and 5.05-50.5 ng/mL for 5-M-THF. The developed LC-MS/MS method offers increased sensitivity for quantification of FA and 5-M-THF in human plasma and was applicable to a pharmacokinetic study of FA and 5-M-THF.
出处 《Journal of Pharmaceutical Analysis》 SCIE CAS 2015年第4期269-275,共7页 药物分析学报(英文版)
关键词 Folic acid 5-Methyltetrahydrofolic acid 2-Mercaptoethanol LC-MS/MS Pharmacokinetics Folic acid 5-Methyltetrahydrofolic acid 2-Mercaptoethanol LC-MS/MS Pharmacokinetics
  • 相关文献

参考文献27

  • 1X.W. Wang, T. Zhang, X. Zhao, et al., Quantification of folate metabolites in serum using ultra-performance liquid chromatography tandem mass spec- trometry, J. Chromatogr. B 962 (2014) 9-13. 被引量:1
  • 2Centers for Disease Control, Use of folic acid for prevention of spina bifida and other neural tube defects - 1983-1991, MMVR Morb. Mortal. Wkly. Rep. 40 (1991) 513-516. 被引量:1
  • 3American Academy of Pediatrics Committee on Genetics, Folic acid for the prevention of neural tube defects, Pediatrics 92 (1993) 493-494. 被引量:1
  • 4H.l. Morrison, D. Schaubel, M. Desmeurles, et al., Serum folate and risk of fatal coronary heart disease, J. Am. Med. Assoc. 275 (1996) 1893-1896. 被引量:1
  • 5W.H. Giles, S.J. Kittner, J.B. Croft, et al., Serum folate and risk for coronary heart disease: results from a cohort of US adults, Ann. Epidemiol. 8 (1998) 490-496. 被引量:1
  • 6N. Sirachainan, S. Wongruangsri, S. Kajanachumpol, et al., Folate pathway genetic polymorphisms and susceptibility of central nervous system tumors in Thai children, Cancer Detect. Prey. 32 (2008) 72-78. 被引量:1
  • 7A.J. Levine, J.C. Figueiredo, W. Lee, et al., A candidate gene study of folate- associated one carbon metabolism genes and coloreetal cancer risk, Cancer Epidemiol. Biomark. Prey. 19 (2010) 1812-1821. 被引量:1
  • 8J.M. Biselli, D. Brumati, V.E Frigeri. et al., A80G polymorphism of reduced folate carrier 1 (RFCI) and C776G polymorphism of transcobalamin 2 (TC2) genes in Down's syndrome etiology, Sao Paulo Med. J. 126 (2008) 329-332. 被引量:1
  • 9G. Gothoni, M. Vuoristo, K. Kontula, High-dose folic acid treatment for red-cell aplasia, Lancet 345 (1995) 1645-1646. 被引量:1
  • 10K. Pietrzik, L. Bailey, B. Shane, Folic acid and l-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics, Clin. Phar- macokinet. 49 (2010) 535-548. 被引量:1

同被引文献14

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部